Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif

Journal of Cell Science

Volumn 112, Issue 5, 1999, Pages 733-747

  Guldner, Hans H ^a   Szostecki, Carin ^a   Schröder, Petra ^a   Matschl, Urte ^a   Jensen, Kirsten ^a   Lüders, Cora ^a   Will, Hans ^a   Sternsdorf, Thomas ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Alternative splicing; High mobility group; HMG box; Interferon; Nuclear dot; PML body; Sp100

Indexed keywords

HIGH MOBILITY GROUP PROTEIN; INTERFERON; MESSENGER RNA; NUCLEAR PROTEIN; PHOSPHOPROTEIN; PROTEIN S 100;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NUCLEAR; AUTOANTIGENS; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE; CLONING, MOLECULAR; EXONS; GENE EXPRESSION; HELA CELLS; HIGH MOBILITY GROUP PROTEINS; HMGB1 PROTEIN; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; VARIATION (GENETICS);

EID: 0032999287     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Alcalay, M., Tomassoni, L., Colombo, E., Stoldt, S., Grignani, F., Fagioli, M., Szekely, L., Helin, K. and Pelicci, P. G. (1998). The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell Biol. 18, 1084-1093.
2. Ascoli, C. A. and Maul, G. G. (1991). Identification of a novel nuclear domain. J. Cell Biol. 112, 785-795.
3. Baxevanis, A. D. and Landsman, D. (1995). The HMG-1 box protein family: classification and functional relationships. Nucl. Acids Res. 23, 1604-1613.
4. Bloch, D. B., de la Monte, S. M., Guigaouri, P., Filippov, A. and Bloch, K. D. (1996). Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem. 271, 29198-29204.
5. Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E. and Freemont, P. S. (1996). PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13, 971-982.
6. Boshart, M., Weber, F., Jahn, G., Dorsch, H. K., Fleckenstein, B. and Schaffner, W. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521-530.
7. Brasch, K. and Ochs, R. L. (1992). Nuclear bodies (NBs): A newly 'rediscovered' organelle. Exp. Cell Res. 202, 211-223.
8. Bustin, M., Lehn, D. A. and Landsman, D. (1990). Structural features of the HMG chromosomal proteins and their genes. Biochim. Biophys. Acta 1049, 231-243.
9. Buwitt, U., Flohr, T. and Bottger, E. C. (1992). Molecular cloning and characterization of an interferon induced human cDNA with sequence homology to a mammalian peptide chain release factor. EMBO J. 11, 489-496.
10. Cao, T., Duprez, E., Borden, K. L., Freemont, P. S. and Etkin, L. D. (1998). Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML. J. Cell Sci. 111, 1319-1329.
11. Carvalho, T., Seeler, J. S., Öhman, K., Jordan, P., Pettersson, U., Akusjärvi, G., Carmo-Fonseca, M. and Dejean, A. (1995). Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131, 45-56.
12. Chan, J. Y., Li, L., Fan, Y. H., Mu, Z. M., Zhang, W. W. and Chang, K. S. (1997). Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML. Biochem. Biophys. Res. Commun. 240, 640-646.
13. Chelbi-Alix, M. K., Pelicano, L., Quignon, F., Koken, M. H. M., Venturini, L., Stadler, M., Pavlovic, J., Degos, L. and de Thé, H. (1995). Induction of the PML protein by interferons in normal and APL cells. Leukemia 9, 2027-2033.
14. Chelbi-Alix, M. K., Quignon, F., Pelicano, L., Koken, M. H. and de Thé, H. (1998). Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72, 1043-1051.
15. Dang, C. V. and Lee, W. M. (1989). Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J. Biol. Chem. 264, 18019-18023.
16. Daniel, M. T., Koken, M. H. M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M. C., Degos, L., Chomienne, C. and de Thé, H. (1993). PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82, 1858-1867.
17. de Thé, H., Riviére, M. and Bernhard, W. (1960). Examen au microscope électronique de la tumeur VX2 du lapin domestique dérivée du papillome de shope. Bull. Cancer 47, 569-584.
18. de Thé, H., Chomienne, C., Lanotte, M., Degos, L. and Dejean, A. (1990). The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347, 558-561.
19. Dent, A. L., Yewdell, J., Puviondutilleul, F., Koken, M. H. M., de Thé, H. and Staudt, L. M. (1996). LYSP100-associated nuclear domains (LANDs): Description of a new class of subnuclear structures and their relationship to PML nuclear bodies. Blood 88, 1423-1436.
20. Dingwall, C. and Laskey, R. A. (1991). Nuclear targeting sequences - a consensus? Trends Biochem. Sci. 16, 478-481.
21. Doucas, V. and Evans, R. M. (1996). The PML nuclear compartment and cancer. Biochim. Biophys. Acya 1288, M25-M29.
22. Dyck, J. A., Maul, G. G., Miller, W. J., Chen, J. D., Kakizuka, A. and Evans, R. M. (1994). A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333-343.
23. Fagioli, M., Alcalay, M., Pandolfi, P. P., Venturini, L., Mencarelli, A., Simeone, A., Acampora, D., Grignani, F. and Pelicci, P. G. (1992). Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7, 1083-1091.
24. Gariglio, M., Ying, G. G., Hertel, L., Gaboli, M., Clerc, R. G. and Landolfo, S. (1997). The high-mobility group protein T160 binds to both linear and cruciform DNA and mediates DNA bending as determined by ring closure. Exp. Cell Res. 236, 472-481.
25. Giese, K., Cox, J. and Grosschedl, R. (1992). The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69, 185-195.
26. Goddard, A. D., Borrow, J., Freemont, P. S. and Solomon, E. (1991). Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371-1374.
27. Gongora, C., David, G., Pintard, L., Tissot, C., Hua, T. D., Dejean, A. and Mechti, N. (1997). Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. biol. Chem. 272, 19457-19463.
28. Grande, M. A., van der Kraan, I., van Steensel, B., Schul, W., de Thé, H., van der Voort, H. T., de Jong, L. and van Driel, R. (1996). PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J. Cell Biochem. 63, 280-291.
29. Gross, C. T. and McGinnis, W. (1996). DEAF-1, a novel protein that binds an essential region in a Deformed response element. EMBO J. 15, 1961-1970.
30. Grosschedl, R. K., Giese, K. and Pagel, J. (1994). HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 10, 94-100.
31. Grötzinger, T., Jensen, K., Guldner, H. H., Sternsdorf, T., Szostecki, C., Schwab, M., Savelyeva, L., Reich, B. and Will, H. (1996a). A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots. Mol. Cell Biol. 16, 1150-1156.
32. Grötzinger, T., Jensen, K. and Will, H. (1996b). The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J. Biol. Chem. 271, 25253-25260.
33. Grötzinger, T., Sternsdorf, T., Jensen, K. and Will, H. (1996c). Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem. 238, 554-560.
34. Guldner, H. H., Lakomek, H. J. and Bautz, F. A. (1986). Anti-(U1)RNP and anti-Sm autoantibody profiles in patients with systemic rheumatic diseases: differential detection of immunoglobulin G and M by immunoblotting. Clin. Immunol. Immunopathol. 40, 532-538.
35. Guldner, H. H., Netter, H. J., Szostecki, C., Jaeger, E. and Will, H. (1990). Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus. J. Exp. Med. 171, 819-829.
36. Guldner, H. H., Szostecki, C., Grötzinger, T. and Will, H. (1992). IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149, 4067-4073.
37. Harlow, E. and Lane, D. (1988). Antibodies: a Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
38. Hartl, P. and Lipp, M. (1987). Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals. Mol. Cell Biol. 7, 2037-2045.
39. Jantzen, H. M., Admon, A., Bell, S. P. and Tjian, R. (1990). Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins. Nature 344, 830-836.
40. Kadereit, S., Gewert, D. R., Galabru, J., Hovanessian, A. G. and Meurs, E. F. (1993). Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins. J. Biol. Chem. 268, 24432-24441.
41. Kakizuka, A., Miller, W. J., Umesono, K., Warrell, R. J., Frankel, S. R., Murty, V. V., Dmitrovsky, E. and Evans, R. M. (1991). Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674.
42. Kamei, H. (1997). Cystine starvation induces reversible large-body formation from nuclear bodies in T24 cells. Exp. Cell Res. 237, 207-216.
43. Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T. and Yeh, E. T. H. (1998). Identification of three major sentrinization sites in PML. J. Biol. Chem. 273, 26675-26682.
44. Koken, M. H., Reid, A., Quignon, F., Chelbi-Alix, M. K., Davies, J. M., Kabarowski, J. H., Zhu, J., Dong, S., Chen, S., Chen, Z. et al. (1997). Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc. Nat. Acad. Sci. USA 94, 10255-10260.
45. Koken, M. H. M., Linares-Cruz, G., Quignon, F., Viron, A., Chelbi-Alix, M. K., Sobczak-Thepot, J., Juhlin, L., Degos, L., Calvo, F. and de Thé, H. (1995). The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10, 1315-1324.
46. Koken, M. H. M., Puvion, D. F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., Chomienne, C. et al. (1994). The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073-1083.
47. Korioth, F., Gieffers, C., Maul, G. G. and Frey, J. (1995). Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J. Cell Biol. 130, 1-13.
48. Lamond, A. I. and Earnshaw, W. C. (1998). Structure and function in the nucleus. Science 280, 547-553.
49. LaMorte, V. J., Dyck, J. A., Ochs, R. L. and Evans, R. M. (1998). Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Nat. Acad. Sci. USA 95, 4991-4996.
50. Laudet, V., Stehelin, D. and Clevers, H. (1993). Ancestry and diversity of the HMG box superfamily. Nucl. Acids Res. 21, 2493-2501.
51. Lavau, C., Marchio, A., Fagioli, M., Jansen, J., Falini, B., Lebon, P., Grosveld, F., Pandolfi, P. P., Pelicci, P. G. and Dejean, A. (1995). The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11, 871-878.
52. LeBoeuf, R. D., Ban, E. M. H., Green, M. M., Stone, A. S., Probst, S. M., Blalock, E. J. and Tauber, J. D. (1998). Molecular cloning, sequence analysis, expression, and tissue distribution of Suppressin, a novel suppressor of cell cycle entry. J. Biol. Chem. 273, 361-368.
53. LeBoeuf, R. D., Burns, J. N., Bost, K. L. and Blalock, J. E. (1990). Isolation, purification, and partial characterization of suppressin, a novel inhibitor of cell proliferation. J. Biol. Chem. 265, 158-165.
54. Lehming, N., Le Saux, A., Schuller, J. and Ptashne, M. (1998). Chromatin components as part of a putative transcriptional repressing complex. Proc. Nat. Acad. Sci. USA 95, 7322-7326.
55. Lovell-Badge, R. (1995). Developmental genetics. Living with bad architecture.. Nature 376, 725-726.
56. Maul, G. G., Yu, E., Ishov, A. M. and Epstein, A. L. (1995). Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J. Cell Biochem. 59, 498-513.
57. Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G. and Chang, K. S. (1994). PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell Biol. 14, 6858-6867.
58. Mu, Z. M., Le, X. F., Glassman, A. B. and Chang, K. S. (1996). The biologic function of PML and its role in acute promyelocytic leukemia. Leuk. Lymphoma 23, 277-285.
59. Müller, S., Matunis, M. J. and Dejean, A. (1998). Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17, 61-70.
60. Ohndorf, U. M., Whitehead, J. P., Raju, N. L. and Lippard, S. J. (1997). Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts. Biochemistry 36, 14807-14815.
61. Plass, C., Weichenhan, D., Kunze, B., Hellwig, T., Schneider, C., Bautz, F. A., Grzeschik, K. H., Traut, W. and Winking, H. (1995). A member of the mouse LRR transcript family with homology to the human Sp100 gene. Hereditas 122, 245-256.
62. Pöhler, J. R., Norman, D. G., Bramham, J., Bianchi, M. E. and Lilley, D. M. (1998). HMG box proteins bind to four-way DNA junctions in their open conformation. EMBO J. 17, 817-826.
63. Quignon, F., De Bels, F., Koken, M., Feunteun, J., Ameisen, J. C. and de Thé, H. (1998). PML induces a novel caspase-independent death process. Nat. Genet. 20, 259-265.
64. Reyes, J. C., Muchardt, C. and Yaniv, M. (1997). Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J. Cell Biol. 137, 263-274.
65. Ross, J. (1995). mRNA stability in mammalian cells. Microbiol. Rev. 59, 423-450.
66. Saitoh, H., Pu, R. T. and Dasso, M. (1997). SUMO-1: wrestling with a new ubiquitin-related modifier. Trends Biochem. Sci. 22, 374-376.
67. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
68. Seeler, J. S., Marchio, A., Sitterlin, D., Transy, C. and Dejean, A. (1998). Interaction of SP100 with HP1 proteins: A link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Nat. Acad. Sci. USA 95, 7316-7321.
69. Shirakawa, H. and Yoshida, M. (1992). Structure of a gene coding for human HMG2 protein. J. Biol. Chem. 267, 6641-6645.
70. Skinner, P. J., Koshy, B. T., Cummings, C. J., Klement, I. A., Helin, K., Servadio, A., Zoghbi, H. Y. and Orr, H. T. (1997). Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971-974.
71. Stadler, M., Chelbi-Alix, M. K., Koken, M. H. M., Venturini L., Lee, C., Saib, A., Quignon, F., Pelicano, L., Guillemin, M. C., Schindler, C. and de Thé, H. (1995). Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11, 2565-2573.
72. Stemler, M., Weimer, T., Tu, Z. X., Wan, D. F., Levrero, M., Jung, C., Pape, G. R. and Will, H. (1990). Mapping of B-cell epitopes of the human hepatitis B virus X protein. J. Virol. 64, 2802-2809.
73. Sternsdorf, T., Grötzinger, T., Jensen, K. and Will, H. (1997a). Nuclear dots: Actors on many stages. Immunobiology 198, 307-331.
74. Sternsdorf, T., Jensen, K. and Will, H. (1997b). Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J. Cell Biol. 139, 1621-1634.
75. Sternsdorf, T., Jensen, K., Züchner, D. and Will, H. (1997c). Cellular localization, expression, and structure of the nuclear dot protein 52. J. Cell Biol. 138, 435-448.
76. Stros, M. and Dixon, G. H. (1993). A retropseudogene for non-histone chromosomal protein HMG-1. Biochim. Biophys. Acta 1172, 231-235.
77. Szostecki, C. (1991). Studien zur Struktur, Expression und Funktion des nukleären Sp100-Autoantigenes und Analyse der humoralen Immunantwort., (ed.: Ludwig-Maximilians-Universität München.
78. Szostecki, C., Krippner, H., Penner, E. and Bautz, F. A. (1987). Autoimmune sera recognize a 100 kD nuclear protein antigen (Sp100). Clin. Exp. Immunol. 68, 108-116.
79. Szostecki, C., Guldner, H. H., Netter, H. J. and Will, H. (1990). Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145, 4338-4347.
80. Szostecki, C., Will, H., Netter, H. J. and Guldner, H. H. (1992). Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution. Scand. J. Immunol. 36, 555-564.
81. Terris, B., Baldin, V., Dubois, S., Degott, C., Flejou, J. F., Henin, D. and Dejean, A. (1995). PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 55, 1590-1597.
82. Tjian, R. and Maniatis, T. (1994). Transcriptional activation: a complex puzzle with few easy pieces. Cell 77, 5-8.
83. Vallian, S., Gaken, J. A., Trayner, I. D., Gingold, E. B., Kouzarides, T., Chang, K. S. and Farzaneh, F. (1997). Transcriptional repression by the promyelocytic leukemia protein, PML. Exp. Cell Res. 237, 371-382.
84. Wang, J. F., Bashir, M., Engelsberg, B. N., Witmer, C., Rozmiarek, H. and Billings, P. C. (1997). High mobility group proteins 1 and 2 recognize chromium-damaged DNA. Carcinogenesis 18, 371-375.
85. Wang, W., Chi, T., Xue, Y., Zhou, S., Kuo, A. and Crabtree, G. R. (1998a). Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes. Proc. Nat. Acad. Sci. USA 95, 492-498.
86. Wang, Z. G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R. and Pandolfi, P. P. (1998b). PML is essential for multiple apoptotic pathways. Nat. Genet. 20, 266-272.
87. Weichenhan, D., Kunze, B., Zacker, S., Traut, W. and Winking, H. (1997). Structure and expression of the murine Sp100 nuclear dot gene. Genomics 43, 298-306.
88. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994). Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76, 345-356.
89. Wen, L., Huang, J. K., Johnson, B. H. and Reeck, G. R. (1989). A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucl. Acids Res. 17, 1197-1214.
90. Wolffe, A. P. (1994). Architectural transcription factors. Science 264, 1100-1111.
91. Xie, K., Lambie, E. J. and Snyder, M. (1993). Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell Biol. 13, 6170-6179.
92. Zheng, P., Guo, Y., Niu, Q., Levy, D. E., Dyck, J. A., Lu, S., Sheiman, L. A. and Liu, Y. (1998). Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature 396, 373-376.